Development of Circulating Molecular Predictors of Chemotherapy and Novel Hormonal Therapy Benefit in Men with Metastatic Castration Resistant Prostate Cancer (mCRPC)

Administered By

Awarded By

Contributors

Start/End

  • August 1, 2014 - August 1, 2019